Our results mirrored theirs; we observed similar trends when examining microarray data after knockdown of MYC in human prostate cancer cell lines, and we observed RNA-Seq results from a clinical trial where responding patients showed reduced MYC was accompanied reduced mRNA levels in genes such as TWNK (Supplemental Figure 6). Here, MYC is linked to prostate cancer.